N/A - Remote Study
Naples, Florida, 34119, United States
Location status: Recruiting
NCT Number: NCT07597603
H22 - Unconscious Mind Training and Memory Encoding
Phase I
The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors.
Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors.
Interested in participating?
Request Info10 year–75 year
All sexes
Interventional
Not applicable
Naples, Florida, 34119, United States
Location status: Recruiting
This investigation will rigorously evaluate: Does H22 demonstrably lower the number of unwanted behaviors reported by participants over the trial period, indicating a tangible and measurable impact?
Timeline for Observable Results: What is the typical duration required to observe statistically significant results and behavioral changes when utilizing the H22 methodology, providing insights into its practical application and patient expectations?
To achieve these objectives, participants will engage in a structured and consistent protocol:
Daily H22 Engagement. Each volunteer will commit to performing the H22 training exercises daily for a continuous period of two weeks. This consistent engagement is crucial for assessing the cumulative impact of the intervention on unconscious conditioning.
Mid-Trial Unconscious Mind Survey: After the first week of the trial, participants will complete a specialized survey. This survey is designed to gather qualitative and quantitative data regarding perception of changes in participants unconscious thought patterns, behavioral triggers, and overall mental state as a result of H22.
Behavioral Monitoring Diary. Participants will maintain a daily diary to meticulously record the number of instances participants successfully remembered not to engage in their specified unwanted behavior. This self-reporting mechanism will provide critical empirical data to track progress and validate the effectiveness of H22 in promoting conscious control over previously unconscious actions.
Through this comprehensive approach, this study endeavors to determine if H22 offers a viable, innovative solution for behavioral modification by targeting the unconscious mind, thereby addressing a significant unmet need in personal development and therapeutic interventions.
The design of the intervention is centered around simplicity and consistency: a once-a-day engagement. This frequency is strategically chosen to:
Minimize Barriers to Entry: A short, daily commitment is less daunting than lengthy, infrequent sessions, increasing user adherence.
Promote Habit Formation: Regular, brief interaction facilitates the establishment of a sustainable routine, crucial for long-term results.
Optimize Efficacy: Consistent, focused engagement. The interventions provided by the Investigator are primarily behavioral. Investigators recognize that sustained improvement with the unconscious mind is more than just instruction; it demands a change in daily habits and a commitment to ongoing self-care.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unconscious Mind Training.
Time frame: From enrollment to the end of treatment at 2 weeks
Time frame: From enrollment to the end of treatment at 2 weeks.
Contact information is provided by the study sponsor or research team.
Dream Video LLC
Other
H22 - Unconscious Mind Training and Memory Encoding
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07721272
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial DetailsNCT07165899
Inhibitory Control, Memory Encoding
Lubbock, Texas, United States
View Trial DetailsNCT07029919
Adolescent Behavior, Asthma
Atlanta, Georgia, United States
View Trial DetailsNCT06949774
Acquired Immunodeficiency Syndrome, Behavior
Kampala, Uganda
View Trial Details